Constitutive and tumor necrosis factor-alpha-stimulated activation of nuclear factor-kappaB in immortalized endometriotic cells and their suppression by trichostatin A
This study found that NF-kappaB is constitutively activated in endometriotic cells, and this activation is suppressed by trichostatin A, which also affects p65 phosphorylation and translocation.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (60)
- Aberrant expression of deoxyribonucleic acid methyltransferases DNMT1, DNMT3A, and DNMT3B in women with endometriosis via openalex
- Aberrant expression of glutathione peroxidase in eutopic and ectopic endometrium in endometriosis and adenomyosis via openalex
- Agents blocking the nuclear factor-kappaB pathway are effective inhibitors of endometriosis in an in vivo experimental model via openalex
- Beta-hydroxyisovalerylshikonin induces apoptosis and G0/G1 cell-cycle arrest of endometriotic stromal cells: a preliminary in vitro study via openalex
- DNA microarray analysis of gene expression in eutopic endometrium from patients with deep endometriosis using laser capture microdissection via openalex
- Effects of oxidants and antioxidants on proliferation of endometrial stromal cells via openalex
- Emerging drugs for endometriosis via openalex
- Endometriosis: a disease of oxidative stress? via openalex
- Endometriosis and tissue factor via openalex
- Endothelial nitric oxide synthase in the endometrium during the menstrual cycle in patients with endometriosis and adenomyosis via openalex
- ESHRE guideline for the diagnosis and treatment of endometriosis via openalex
- Estrogen receptor (ER) beta regulates ERalpha expression in stromal cells derived from ovarian endometriosis via openalex
- Human chorionic gonadotrophin attenuates NF-kappaB activation and cytokine expression of endometriotic stromal cells via openalex
- Identification of an invasive, N-cadherin-expressing epithelial cell type in endometriosis using a new cell culture model via openalex
- Inhibition of proliferation of endometrial stromal cells by trichostatin A, RU486, CDB-2914, N-acetylcysteine, and ICI 182780 via openalex
- Interleukin-10 attenuates TNF-alpha-induced interleukin-6 production in endometriotic stromal cells via openalex
- Involvement of nuclear factor-kappaB in macrophage migration inhibitory factor gene transcription up-regulation induced by interleukin- 1 beta in ectopic endometrial cells via openalex
- Lack of association of the common immunologically anomalous LH with endometriosis via openalex
- Medical management of endometriosis: novel targets and approaches towards the development of future treatment regimes via openalex
- Nonmalignant epithelial cells, potentially invasive in human endometriosis, lack the tumor suppressor molecule E-cadherin via openalex
- Nuclear factor-kappa B is constitutively activated in peritoneal endometriosis via openalex
- Nuclear factor-kappab (NF-kappaB): an unsuspected major culprit in the pathogenesis of endometriosis that is still at large? via openalex
- Obstructive uropathy from endometriosis after hysterectomy and oophorectomy; two case reports via openalex
- Oxidative stress and peritoneal endometriosis via openalex
- Peroxisome proliferator-activated receptor-gamma ligand reduced tumor necrosis factor-alpha-induced interleukin-8 production and growth in endometriotic stromal cells via openalex
- Progesterone receptor isoform A but not B is expressed in endometriosis via openalex
- Prolonged stimulation with tumor necrosis factor-alpha induced partial methylation at PR-B promoter in immortalized epithelial-like endometriotic cells via openalex
- Promoter hypermethylation of progesterone receptor isoform B (PR-B) in endometriosis via openalex
- RU486-induced growth inhibition of human endometrial cells via openalex
- Selective inhibition of prostaglandin E2 receptors EP2 and EP4 induces apoptosis of human endometriotic cells through suppression of ERK1/2, AKT, NFkappaB, and beta-catenin pathways and activation of intrinsic apoptotic mechanisms via openalex
- Suppression of IL-1beta-induced COX-2 expression by trichostatin A (TSA) in human endometrial stromal cells via openalex
- TAK1 activation for cytokine synthesis and proliferation of endometriotic cells via openalex
- Trichostatin A, a histone deacetylase inhibitor, attenuates invasiveness and reactivates E-cadherin expression in immortalized endometriotic cells via openalex
- Tumor necrosis factor-alpha induced the release of interleukin-6 from endometriotic stromal cells by the nuclear factor-kappaB and mitogen-activated protein kinase pathways via openalex
- Uterine cavity matrix metalloproteinases and cytokines in patients with leiomyoma, adenomyosis or endometrial polyp via openalex
- W1984756562 via openalex
- W2059969460 via openalex
- W1980415233 via openalex
- W2066868766 via openalex
- W1980166683 via openalex
- W2075768627 via openalex
- W2083230754 via openalex
- W1921336451 via openalex
- W1575383081 via openalex
- W2106877484 via openalex
- W1568529372 via openalex
- W1564274931 via openalex
- W1548219170 via openalex
- W1536798405 via openalex
- W2157100128 via openalex
- W2157992168 via openalex
- W2006347202 via openalex
- W1512318310 via openalex
- W2001963326 via openalex
- W1992744008 via openalex
- W2039395669 via openalex
- W2049619918 via openalex
- W1987536174 via openalex
- W1986743005 via openalex
- W2056402897 via openalex
Cited by (18)
- Precision medicine approaches for targeted therapy in endometriosis: A promising future 2026
- Research Progress of Histone Deacetylase and Its Inhibitors in Endometriosis 2026
- High Expression of PR-A and Low Expression of PR-B is Correlated with Inflammation in Endometrioma Cases 2023
- The Impact of Histone Modifications in Endometriosis Highlights New Therapeutic Opportunities 2023
- An Update on the Multifaceted Role of NF-kappaB in Endometriosis 2022
- Plasma High Mobility Group Box 1 (HMGB1), Osteopontin (OPN), and Hyaluronic Acid (HA) as Admissible Biomarkers for Endometriosis 2019
- Aberrant histone modification in endometriosis 2014
- Potential New Drugs for Endometriosis: Experimental Evidence 2014
- Endometriotic Epithelial Cell Response to Macrophage-Secreted Factors is Dependent on Extracellular Matrix Context 2014
- Developmental exposure of fetal ovaries and fetal germ cells to endometriosis in an endometriosis model causes differential gene expression in the preimplantation embryos of the first-generation and second-generation embryos 2013
- The Epigenetics of Endometriosis 2012
- Dysmenorrhea and its severity are associated with increased uterine contractility and overexpression of oxytocin receptor (OTR) in women with symptomatic adenomyosis 2012
- Valproic acid and progestin inhibit lesion growth and reduce hyperalgesia in experimentally induced endometriosis in rats 2012
- Histone deacetylase inhibitors as therapeutics for endometriosis 2012
- Valproic acid alleviates generalized hyperalgesia in mice with induced adenomyosis 2011
- Application of the histone deacetylase inhibitors for the treatment of endometriosis: histone modifications as pathogenesis and novel therapeutic target 2011
- Promoter hypermethylation of progesterone receptor isoform B (PR-B) in adenomyosis and its rectification by a histone deacetylase inhibitor and a demethylation agent 2010
- Levo-tetrahydropalmatine retards the growth of ectopic endometrial implants and alleviates generalized hyperalgesia in experimentally induced endometriosis in rats 2010
Source provenance
- europepmc
- last seen: 2026-10-10T06:11:15.153948+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:07:19.155540+00:00